Success Stories: EB-1A Petition Approved for Associate Research Scientist in the Field of Drug Discovery in Just 8 Days, Special Thanks to PP

 

Client’s Testimonial:

"Thanks a lot to your team for helping me in this case.”


On March 10th, 2020, we received another EB-1A (Alien of Extraordinary Ability) approval for an Associate Research Scientist in the Field of Drug Discovery (Approval Notice).


General Field: Drug Discovery

Position at the Time of Case Filing: Associate Research Scientist

Country of Origin: India

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: March 10th, 2020

Processing Time: 8 days (PP requested)


Case Summary:

Our client, an associate research scientist from India who specializes in the field of drug discovery focusing on utilizing medicinal chemistry and natural products chemistry techniques to discover new drugs for cancer, infectious diseases and disorders of the heart and lungs, hired our firm to present a convincing EB-1A case to the USCIS.

By submitting evidence of the research success - 25 peer-reviewed scientific articles, one book chapter, and one patent and his experience of judging the work of his peers for 26 times, we established the fact that our client is an extraordinary researcher who deserves to remain in the United States to conduct his impactful research. We also detailed the 491 times his work was cited by other leading and influential researchers around the world. Since EB-1A is one of the toughest I-140 categories, we made sure that we thoroughly presented our client’s achievements in a clear and concise manner.

The customized EB-1A petition packet which we arranged for our client contained an array of information that highlighted his research achievements. We also included several recommendation letters contributed by other well-known figures in the field. One of the recommenders stated that: “Drug discovery is an important field that affects us all. Developing novel ways of treating diseases improves public health and quality of life. This is an urgent priority for the field, and [client’s] research is on the cutting edge of this front. His research is aiding in the advancement of drug development, and it is in the United States' best interest to support his work.”

In addition to carefully assembling the required documents to file the EB-1A petition on behalf of our client, our team has included customized figures and tables for visualization to indicate that our client’s publications have been cited at a much higher rate than those of other researchers in the field, distinguishing him from his peers. The visual presentation of the data has indeed further demonstrated and supported the argument in the petition letter drafted by us.

With abundant experience working with clients in virtually all fields of expertise, we are well equipped to handle every circumstance that might arise when filing an I-140 immigration petition. We truly appreciate our client for trusting us with the preparation of his EB-1A case and for giving us an opportunity to be a part of his success story.